HomeCompareSMKUY vs MRK

SMKUY vs MRK: Dividend Comparison 2026

SMKUY yields 45.63% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $24.3K in total portfolio value· pulled ahead in Year 7
10 years
SMKUY
SMKUY
● Live price
45.63%
Share price
$1.00
Annual div
$0.46
5Y div CAGR
-42%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.5K
Annual income
$32.40
Full SMKUY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SMKUY vs MRK

📍 MRK pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMKUYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMKUY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMKUY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMKUY
Annual income on $10K today (after 15% tax)
$3,878.13/yr
After 10yr DRIP, annual income (after tax)
$27.54/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,300.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMKUY + MRK for your $10,000?

SMKUY: 50%MRK: 50%
100% MRK50/50100% SMKUY
Portfolio after 10yr
$44.6K
Annual income
$4,915.27/yr
Blended yield
11.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SMKUY
No analyst data
Altman Z
1.8
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMKUY buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMKUYMRK
Forward yield45.63%2.76%
Annual dividend / share$0.46$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-42%32.7%
Portfolio after 10y$32.5K$56.8K
Annual income after 10y$32.40$9,798.13
Total dividends collected$7.7K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SMKUY vs MRK ($10,000, DRIP)

YearSMKUY PortfolioSMKUY Income/yrMRK PortfolioMRK Income/yrGap
1$13,346$2,646.25$11,206$366.19+$2.1KSMKUY
2$16,195$1,914.41$12,650$502.35+$3.5KSMKUY
3$18,588$1,259.21$14,407$694.19+$4.2KSMKUY
4$20,672$783.41$16,585$967.82+$4.1KSMKUY
5$22,592$472.28$19,342$1,363.89+$3.3KSMKUY
6$24,453$279.77$22,913$1,947.19+$1.5KSMKUY
7← crossover$26,329$164.14$27,662$2,823.89$1.3KMRK
8$28,267$95.80$34,159$4,173.35$5.9KMRK
9$30,302$55.75$43,337$6,308.80$13.0KMRK
10$32,455$32.40$56,776$9,798.13$24.3KMRK

SMKUY vs MRK: Complete Analysis 2026

SMKUYStock

Siam Makro Public Company Limited operates cash and carry trade centers under the Makro name. It operates through Cash and Carry, Retail, Mall Rental, and Food Services segments. The company's trade centers sell food and non-food products to registered members, including small and medium-sized businesses, retailers, caterers, professional sectors, and institutions. It offers freight, delivery rental, and storage services; marketing and consulting services; and imports, exports, trades in, and distributes food products. The company is also involved in the provision of technical and support services; trading of non-food products; investing and operation of retail business and mall rental activities; importing and trading of frozen and chilled foods; telecommunication business; and operation of restaurant and minimart. As of December 31, 2021, it operated 135 Makro stores and 7 frozen shops. The company was incorporated in 1988 and is headquartered in Bangkok, Thailand. Siam Makro Public Company Limited is a subsidiary of CP ALL Public Company Limited.

Full SMKUY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SMKUY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMKUY vs SCHDSMKUY vs JEPISMKUY vs OSMKUY vs KOSMKUY vs MAINSMKUY vs JNJSMKUY vs ABBVSMKUY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.